Our scientific focus is on the molecular events that regulate epigenetic reprogramming in stem cells and the germline.  Our future goal is to develop  stem cell-based approaches to restore lost or damage tissues following cancer therapy, including loss of germline cells in order to improve quality of life for all childhood cancer survivors in the future.

Our lab is funded by the following sources: National Institutes of Health (NIH), California Institute for Regenerative Medicine (CIRM), Lalor Foundation and the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research